Bernie Schuler has received an MBA from the University of California at Berkley and has over 20 years of private equity experience focusing on the healthcare industry. Most recently he co-headed the German speaking countries on behalf of Bridgepoint GmbH as its Managing Director. Before that he led the global healthcare team of 3i Buyouts as a partner. In addition, he has been a senior advisor to Novo A/S with regards to various healthcare opportunities. Through these positions, Bernie led numerous private equity transactions and had engagements with renowned healthcare companies such as betapharm, Lichtwer, Synlab, xellia, Pulsion Medical Systems, Doc Morris and Rodenstock.

Areas of expertise

  • Investment Strategy
  • Pharmaceutical Business Development
  • Transaction Structuring
  • M&A Execution
  • Restructuring Expertise
  • Post Merger Integration
  • New Product Development
  • Regional Expansion Strategies


  • B.A. in Economics, The Claremont Colleges, USA
  • Magister, BWL, University of Vienna
  • MBA, University of California at Berkeley

© 2017 Stradoo. All rights reserved.